Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 80: | Line 80: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Precursor B-cell Lymphoma | * Precursor B-cell Lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 111: | Line 111: | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |[[Follicular lymphoma]] | ! colspan="2" align="center" style="background:#DCDCDC;" + |[[Follicular lymphoma]] | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
* Reciprocal translocation t(14;18)(q32;q21) | * Reciprocal translocation t(14;18)(q32;q21) | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
*[[Fever]] | *[[Fever]] | ||
*[[Weight loss]] | *[[Weight loss]] | ||
*[[Night sweats]] | *[[Night sweats]] | ||
| + | | align="center" style="background:#F5F5F5;" + |+ | ||
| + | | align="center" style="background:#F5F5F5;" + |+ | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Painless swelling in the neck, axilla, groin, thorax and abdomen | * Painless swelling in the neck, axilla, groin, thorax and abdomen | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Central and peripheral lymphadenopathy | * Central and peripheral lymphadenopathy | ||
| + | | align="center" style="background:#F5F5F5;" + |+ | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* [[Seizures]] | * [[Seizures]] | ||
*[[Chest pain]] | *[[Chest pain]] | ||
Line 138: | Line 138: | ||
*[[Cough]] | *[[Cough]] | ||
*[[Dyspnea]] | *[[Dyspnea]] | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Mantle cell lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Mantle cell lymphoma | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | * [[CD5 (protein)|CD5]] positive antigen in pregerminal center of B-cell | ||
* [[Chromosomal translocation]] at '''t(11:14)''' | * [[Chromosomal translocation]] at '''t(11:14)''' | ||
** Over-express [[cyclin D1]] | ** Over-express [[cyclin D1]] | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Stage IV disease | * Stage IV disease | ||
* B symptoms, | * B symptoms, | ||
Line 170: | Line 170: | ||
* Weight Loss | * Weight Loss | ||
* Extranodal involvement of gastrointtestinal (GI) tract, lungs, and central nervous system (CNS) | * Extranodal involvement of gastrointtestinal (GI) tract, lungs, and central nervous system (CNS) | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
* Generalized lymphadenopathy | * Generalized lymphadenopathy | ||
* Hepato-splenomegaly | * Hepato-splenomegaly | ||
Line 180: | Line 180: | ||
* Less commonly | * Less commonly | ||
** Palpable masses in skin, breast, and salivary glands | ** Palpable masses in skin, breast, and salivary glands | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|CBC | | align="center" style="background:#F5F5F5;" + |CBC | ||
* Anemia and cytopenias are secondary to bone marrow infiltration | * Anemia and cytopenias are secondary to bone marrow infiltration | ||
* Lymphocytosis > 4000/µL | * Lymphocytosis > 4000/µL | ||
* Elevated LDH | * Elevated LDH | ||
* | * | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* CD5<sup>+</sup> | * CD5<sup>+</sup> | ||
* B-cell antigen positive | * B-cell antigen positive | ||
Line 201: | Line 201: | ||
** CD22 | ** CD22 | ||
* Cyclin D1 is overexpressed. | * Cyclin D1 is overexpressed. | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Germinal centers filled by small-to-medium atypical lymphocytes. | * Germinal centers filled by small-to-medium atypical lymphocytes. | ||
* Nodular appearance may be evident from expansion of the mantle zone in 30-50% of patients early in the disease. | * Nodular appearance may be evident from expansion of the mantle zone in 30-50% of patients early in the disease. | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! | ! | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Diffuse large B cell lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Diffuse large B cell lymphoma | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
* 8q24/''MYC'' [[translocations]] | * 8q24/''MYC'' [[translocations]] | ||
Line 217: | Line 217: | ||
* Mutation of ''BCL6'', ''MYC'', ''[[PAX5]]'', ''[[PIM1]]'', ''[[RhoH]]'' /''TTFn'', ''[[TP53]]'' genes | * Mutation of ''BCL6'', ''MYC'', ''[[PAX5]]'', ''[[PIM1]]'', ''[[RhoH]]'' /''TTFn'', ''[[TP53]]'' genes | ||
* Translocations involving ''c-MYC'', ''BCL6'', and ''IgH'' gene. | * Translocations involving ''c-MYC'', ''BCL6'', and ''IgH'' gene. | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Fever | * Fever | ||
* Night sweats | * Night sweats | ||
* weight loss | * weight loss | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Painless rapidly enlarging [[lymph nodes]] | * Painless rapidly enlarging [[lymph nodes]] | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
|↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
|Nl to ↓ | | align="center" style="background:#F5F5F5;" + |Nl to ↓ | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
* | * | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
'''Centroblastic''' | '''Centroblastic''' | ||
*Medium-to-large-sized [[Lymphocyte|lymphocytes]] | *Medium-to-large-sized [[Lymphocyte|lymphocytes]] | ||
Line 252: | Line 252: | ||
'''Anaplastic''' | '''Anaplastic''' | ||
*Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells | *Very large cells with a round, oval, or polygonal shape that may resemble Reed-Sternberg cells | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Hypergammaglobulinemia | * Hypergammaglobulinemia | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Category |
Revision as of 19:03, 31 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | ||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
|
|
CBC
|
|
|
|||||||||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic
|
|
||||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
|||||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |